Education
About Us
Working with TipRanks
Follow Us
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
RESEARCH TOOLSreports
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 6.64B | ¥ 6.61B | ¥ 6.32B | ¥ 5.00B | ¥ 4.51B |
| Gross Profit | ¥ 5.32B | ¥ 4.98B | ¥ 5.00B | ¥ 3.92B | ¥ 3.61B |
| Operating Income | ¥ 848.05M | ¥ 711.80M | ¥ 862.50M | ¥ 687.90M | ¥ 565.66M |
| EBITDA | ¥ 1.35B | ¥ 1.08B | ¥ 1.09B | ¥ 939.71M | ¥ 787.99M |
| Net Income | ¥ 733.16M | ¥ 714.76M | ¥ 930.87M | ¥ 1.51B | ¥ 669.53M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 1.94B | ¥ 2.02B | ¥ 2.62B | ¥ 2.18B | ¥ 3.27B |
| Total Assets | ¥ 11.51B | ¥ 10.85B | ¥ 10.78B | ¥ 10.16B | ¥ 10.94B |
| Total Debt | ¥ 1.21B | ¥ 1.43B | ¥ 1.51B | ¥ 1.64B | ¥ 3.30B |
| Net Debt | ¥ -733.70M | ¥ -577.94M | ¥ -150.86M | ¥ 662.74M | ¥ 29.78M |
| Total Liabilities | ¥ 4.44B | ¥ 3.63B | ¥ 3.64B | ¥ 3.70B | ¥ 5.61B |
| Stockholders' Equity | ¥ 7.07B | ¥ 7.22B | ¥ 7.13B | ¥ 6.44B | ¥ 5.30B |
| Cash Flow | |||||
| Free Cash Flow | ¥ 628.54M | ¥ -828.81M | ¥ 676.71M | ¥ -411.46M | ¥ -256.11M |
| Operating Cash Flow | ¥ 1.39B | ¥ 151.05M | ¥ 1.35B | ¥ -201.97M | ¥ 96.73M |
| Investing Cash Flow | ¥ -1.05B | ¥ 1.09B | ¥ 68.31M | ¥ -435.50M | ¥ 529.08M |
| Financing Cash Flow | ¥ -407.40M | ¥ -894.83M | ¥ -753.68M | ¥ -1.62B | ¥ 2.35B |
Simcere Pharmaceutical Group Limited Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.